EMB and neoplasm: We assessed the antigen specific immune response against peptides for gp70 (the immunodominant antigen in CT26WT tumor model and a common murine tumor-associated antigen that is highly expressed) and VSV N following combined therapy or controls using an IFN-γ ELISPOT assay.